about
Increased red cell distribution width in Fanconi anemia: a novel marker of stress erythropoiesis.Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine.Bone marrow cell transcripts from Fanconi anaemia patients reveal in vivo alterations in mitochondrial, redox and DNA repair pathways.Use of hybrid chitosan membranes and human mesenchymal stem cells from the Wharton jelly of umbilical cord for promoting nerve regeneration in an axonotmesis rat model.Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential.Use of poly(DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly of the umbilical cord for promoting nerve regeneration in axonotmesis: in vitro and in vivo analysis.Protective effect of acetyl-l-carnitine and α-lipoic acid against the acute toxicity of diepoxybutane to human lymphocytes.Normal red blood cells partially decrease diepoxybutane-induced chromosome breakage in cultured lymphocytes from Fanconi anaemia patients.Multiple genotoxic activities of ptaquiloside in human lymphocytes: aneugenesis, clastogenesis and induction of sister chromatid exchange.Role of haemoglobin in the protection of cultured lymphocytes against diepoxybutane (DEB), assessed by in vitro induced chromosome breakage.Occupational exposure to formaldehyde: genotoxic risk evaluation by comet assay and micronucleus test using human peripheral lymphocytes.Cytogenetic and immunological effects associated with occupational formaldehyde exposure.The role of foetal red blood cells in protecting cultured lymphocytes against diepoxybutane-induced chromosome breaks.Fosfomycin increases chromosome instability in lymphocytes from Fanconi Anemia patientsCytogenetic findings in a patient presenting simultaneously with chronic lymphocytic leukemia and acute myeloid leukemiaMitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial DysfunctionRat Olfactory Mucosa Mesenchymal Stem/Stromal Cells (OM-MSCs): A Characterization Study
P50
Q33434120-A56A39D4-566A-4F9A-BFAD-453D1AAE6ADEQ34638291-C78BC525-255F-4D47-AC94-0596E8B89740Q34707383-7861CE31-F1DD-479C-B36A-E798C11EA39FQ34720200-4600D322-D0E0-4F32-95B7-4B95EA4B8D9BQ34870512-A69CACCB-2732-4A09-8E72-0278325B16E3Q35806891-4387F1F3-D560-4B15-98CA-37698CCA2230Q39246656-F1428BCC-9C90-442B-942A-85855302321FQ42728505-3B6CD5A5-4C5C-4CDF-A647-DEB419A0517EQ42840252-DC964CBF-FE60-4973-865F-3FDBBD85B4C7Q43997551-0950446B-7179-45E4-9B55-58895EE5282CQ44403100-8D630BB3-2709-4E1E-8B35-8C566013D198Q44566065-CA3EF7DA-AD1E-4741-AE8F-8848B3342965Q46764302-5ECA08AD-1B12-43B9-B335-4AFDC0195589Q46868977-5156C111-796B-4014-B8CB-DB97028A22F5Q59565184-6F91D278-84D5-4256-82B9-4666CEBEF6C3Q60429963-E7B21E94-FF67-4F25-A966-FDECAD2431D9Q92814238-4D118517-8F38-47C7-8F49-250F15AFF398Q94922730-D165754D-8B1D-4D08-8436-C7E7B08BA511
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Beatriz Porto
@ast
Beatriz Porto
@en
Beatriz Porto
@es
Beatriz Porto
@nl
Beatriz Porto
@sl
type
label
Beatriz Porto
@ast
Beatriz Porto
@en
Beatriz Porto
@es
Beatriz Porto
@nl
Beatriz Porto
@sl
altLabel
B Porto
@en
prefLabel
Beatriz Porto
@ast
Beatriz Porto
@en
Beatriz Porto
@es
Beatriz Porto
@nl
Beatriz Porto
@sl
P106
P1153
6505881552
P21
P31
P496
0000-0003-4281-5438